Ian Bolland is joined by Bernard Ross, CEO of Sky Medical to discuss keeping up the innovation momentum that has developed since the Coronavirus outbreak.
Advanced Workplace Associates founder Andrew Mawson and Chris Hood, director of Consulting, EMEA examine how pharmaceutical leaders can maximise the performance of any virtual or hybrid teams.
Reece Armstrong speaks to Cathal Friel, chairman and co-founder of Open Orphan, about the company's involvement in setting up the first human challenge study model for Covid-19 and the importance of studying the virus during the pandemic.
Karen Tyrrell, Quality Assurance Lead at Pfizer CentreOne discusses the key considerations around the classification and handling of active pharmaceutical ingredients.
Brian Flatley, vice president of Consulting Services at S3 Connected Health looks at the digital health landscape and what its adoption means within pharma.
Pamela Spicer, principal analyst at Informa Pharma Intelligence looks at Biogen's recently approved Alzheimer's drug and questions its rollout in countries outside of the US.
For UK diabetes week, Ian Bolland speaks to Ascensia Diabetes Care to talk about how patients can manage their condition and the digital technologies being used to help people with diabetes.
EPM speaks to Gareth Bakewell, joint managing director at Reelvision about the evolution of packaging technologies in pharma and what this means for the safety of medicines.
Udo Losehand, head of Global Technical Developers at Roquette looks at the benefits precision dispensing technology can offer biopharma manufacturers thanks to its versatility and customisability.
Kevin Seaver, general manager, Bioprocess Automation and Digital, Bioprocess Program at Cytiva explores the digital age of bioprocessing and how manufacturers are benefitting from advancements in the sector.
